Patrick J Heron - Net Worth and Insider Trading

Patrick J Heron Net Worth

The estimated net worth of Patrick J Heron is at least $698 Million dollars as of 2025-01-12. Patrick J Heron is the Director of Vaxcyte Inc and owns about 2,309,554 shares of Vaxcyte Inc (PCVX) stock worth over $187 Million. Patrick J Heron is the Director of Mirum Pharmaceuticals Inc and owns about 3,729,220 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $154 Million. Patrick J Heron is also the Director of Arcutis Biotherapeutics Inc and owns about 8,817,666 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $122 Million. Besides these, Patrick J Heron also holds Imago BioSciences Inc (IMGO) , MBX Biosciences Inc (MBX) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) . Details can be seen in Patrick J Heron's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick J Heron has not made any transactions after 2024-09-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Patrick J Heron

To

Patrick J Heron Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick J Heron owns 20 companies in total, including Tarsus Pharmaceuticals Inc (TARS) , Iterum Therapeutics PLC (ITRM) , and Vaxcyte Inc (PCVX) among others .

Click here to see the complete history of Patrick J Heron’s form 4 insider trades.

Insider Ownership Summary of Patrick J Heron

Ticker Comapny Transaction Date Type of Owner
TARS Tarsus Pharmaceuticals Inc 2020-10-15 10 percent owner
ITRM Iterum Therapeutics PLC 2019-05-24 director & 10 percent owner
PCVX Vaxcyte Inc 2020-06-16 director
LIMIT LIMIT 2019-10-24 10 percent owner
LIMIT LIMIT 2024-09-18 director & 10 percent owner
LIMIT LIMIT 2020-03-03 director & 10 percent owner
LIMIT LIMIT 2024-03-04 director & 10 percent owner
LIMIT LIMIT 2018-09-25 10 percent owner
LIMIT LIMIT 2017-07-24 10 percent owner
LIMIT LIMIT 2018-06-20 10 percent owner
LIMIT LIMIT 2017-01-25 10 percent owner
LIMIT LIMIT 2017-02-14 10 percent owner
LIMIT LIMIT 2016-11-01 director
LIMIT LIMIT 2015-05-12 director & 10 percent owner
LIMIT LIMIT 2015-06-24 10 percent owner
LIMIT LIMIT 2015-04-20 director
LIMIT LIMIT 2021-07-20 director
LIMIT LIMIT 2020-12-08 director
LIMIT LIMIT 2022-04-28 director & 10 percent owner
LIMIT LIMIT 2020-12-08 director

Patrick J Heron Latest Holdings Summary

Patrick J Heron currently owns a total of 9 stocks. Among these stocks, Patrick J Heron owns 2,309,554 shares of Vaxcyte Inc (PCVX) as of June 16, 2020, with a value of $187 Million and a weighting of 26.81%. Patrick J Heron owns 3,729,220 shares of Mirum Pharmaceuticals Inc (MIRM) as of September 18, 2024, with a value of $154 Million and a weighting of 22.06%. Patrick J Heron also owns 8,817,666 shares of Arcutis Biotherapeutics Inc (ARQT) as of March 4, 2024, with a value of $122 Million and a weighting of 17.44%. The other 6 stocks Imago BioSciences Inc (IMGO) , MBX Biosciences Inc (MBX) , Collegium Pharmaceutical Inc (COLL) , Passage Bio Inc (PASG) , Cidara Therapeutics Inc (CDTX) , Iterum Therapeutics PLC (ITRM) have a combined weighting of 33.69% among all his current holdings.

Latest Holdings of Patrick J Heron

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PCVX Vaxcyte Inc 2020-06-16 2,309,554 81.08 187,258,638
MIRM Mirum Pharmaceuticals Inc 2024-09-18 3,729,220 41.32 154,091,370
ARQT Arcutis Biotherapeutics Inc 2024-03-04 8,817,666 13.81 121,771,967
IMGO Imago BioSciences Inc 2021-07-20 2,971,274 36.01 106,995,577
MBX MBX Biosciences Inc 2024-09-16 4,552,774 13.69 62,327,476
COLL Collegium Pharmaceutical Inc 2015-05-12 1,887,332 32.91 62,112,096
PASG Passage Bio Inc 2020-03-03 5,009,219 0.67 3,356,177
CDTX Cidara Therapeutics Inc 2015-04-20 14,551 24.00 349,224
ITRM Iterum Therapeutics PLC 2018-05-30 102,554 1.65 169,214

Holding Weightings of Patrick J Heron


Patrick J Heron Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick J Heron has made a total of 1 transactions in Vaxcyte Inc (PCVX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vaxcyte Inc is the acquisition of 250,000 shares on June 16, 2020, which cost Patrick J Heron around $4 Million.

According to the SEC Form 4 filings, Patrick J Heron has made a total of 6 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 115 shares on September 18, 2024, which cost Patrick J Heron around $4,301.

According to the SEC Form 4 filings, Patrick J Heron has made a total of 2 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the acquisition of 21,052 shares on March 4, 2024, which cost Patrick J Heron around $199,994.

More details on Patrick J Heron's insider transactions can be found in the Insider Trading History of Patrick J Heron table.

Insider Trading History of Patrick J Heron

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick J Heron Trading Performance

GuruFocus tracks the stock performance after each of Patrick J Heron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patrick J Heron is 7.07%. GuruFocus also compares Patrick J Heron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patrick J Heron within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Patrick J Heron's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Patrick J Heron

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
8 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.86 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.34 LIMIT LIMIT LIMIT LIMIT LIMIT

Patrick J Heron Ownership Network

Ownership Network List of Patrick J Heron

No Data

Ownership Network Relation of Patrick J Heron

Insider Network Chart

Patrick J Heron Owned Company Details

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Patrick J Heron is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Patrick J Heron made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 194,315 shares made by Bobak R. Azamian , a net sale of 12,792 shares made by Bryan Wahl , and a net sale of 12,669 shares made by Dianne C. Whitfield .

In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 281,122 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 270,616 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

Patrick J Heron Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick J Heron. You might contact Patrick J Heron via mailing address: 550 Hamilton Ave., Suite 100, Palo Alto Ca 94301.